MD Anderson Cancer Center/University of Texas — Houston, Texas

MD Anderson Cancer Center/University of Texas is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

MD Anderson Cancer Center/University of Texas has participated in 9 clinical trials.

Therapeutic areas: Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer Center/University of Texas?

MD Anderson Cancer Center/University of Texas has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer Center/University of Texas conducted?

MD Anderson Cancer Center/University of Texas has 9 clinical trials on record. Their work covers Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome.

Is MD Anderson Cancer Center/University of Texas accredited by Crixeo Health?

MD Anderson Cancer Center/University of Texas has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson Cancer Center/University of Texas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.